DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Parexel International (NASDAQ: PRXL)

59.76 -1.66 (-2.70%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PRXL $59.76 -2.70%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.00
Previous Close $61.42
Daily Range $59.44 - $62.42
52-Week Range $57.01 - $76.17
Market Cap $3.2B
P/E Ratio 24.97
Dividend (Yield) $0.00 (0.0%)
Volume 739,238
Average Daily Volume 751,500
Current FY EPS $3.28




Healthcare IT

Parexel International (PRXL) Description

The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Website:

News & Commentary

4 Disruptive Stocks Biotechs Depend On

Contract research organizations Quintiles (Q), Icon PLC (ICLR), Covance (CVD), and Parexel (PRXL) are redefining how biopharma discovers and develops new therapies.

PAREXEL International's (PRXL) CEO Josef van Rickenbach on Q2 2016 Results - Earnings Call Transcrip

PAREXEL International's (PRXL) CEO Josef van Rickenbach on Q2 2016 Results - Earnings Call Transcript

PAREXEL International Q2 Earnings Beat, FY16 View Slashed

Parexel International (PRXL) Is Water-Logged And Getting Wetter Today

Trade-Ideas: Parexel International (PRXL) Is Today's Post-Market Leader Stock

Avondale Downgrades PAREXEL To Underperform, Cites MSA-Laden Backlog Concerns

PAREXEL International Set to Acquire Health Advances

PRXL Crosses Below Key Moving Average Level

Benzinga's Top Upgrades

Insider Trading Alert - QTS, PRXL And BKU Traded By Insiders

PAREXEL International: Direct Exposure To A Growing Healthcare Sector

See More PRXL News...

PRXL's Top Competitors

PRXL $59.76 (-2.70%)
Current stock: PRXL
TMO $123.18 (-3.62%)
Current stock: TMO
ILMN $136.05 (-5.11%)
Current stock: ILMN
WAT $115.47 (-2.08%)
Current stock: WAT